Novel multinutrient human milk-based human milk fortifier promotes growth and tolerance in premature infants.
enteral nutrition
human milk
neonates
pediatrics
Journal
JPEN. Journal of parenteral and enteral nutrition
ISSN: 1941-2444
Titre abrégé: JPEN J Parenter Enteral Nutr
Pays: United States
ID NLM: 7804134
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
pubmed:
10
8
2021
medline:
28
5
2022
entrez:
9
8
2021
Statut:
ppublish
Résumé
The objective of this study was to determine whether human milk supplemented with a novel human milk-based human milk fortifier (Novel HMF), compared with a bovine milk-based HMF (Bovine HMF), supports preterm infant growth through 36 weeks' postmenstrual age (PMA). This single-center, prospective trial compared growth and nutrition outcomes of preterm infants provided a human milk-based diet (mother's own milk or donor milk) supplemented with a Novel HMF with historic controls provided Bovine HMF. Preterm infants with an estimated gestational age (EGA) between 23 and 33 weeks' PMA and birth weight between 750 and 1800 g were eligible for study inclusion. Weight, length, and head circumference (HC) were monitored weekly. The occurrence of late-onset sepsis, nil per os (NPO) days, necrotizing enterocolitis, metabolic acidosis, and serious adverse events were monitored. Birth weight, length, HC, and EGA were similar between the Novel HMF (n = 37) and Bovine HMF (n = 49) groups. The days to regain birth weight was shorter in the Novel HMF group (9.4 ± 4.0 vs 11.4 ± 4.8, P = .0343), with similar weight gain (g/day) from birth to 36 weeks' PMA. Adjusted weight growth velocity (g/kg/day) was significantly higher in the Novel HMF group at 14 and 21 days but similar at 36 weeks' PMA. The Novel HMF group experienced fewer NPO days with a similar total number of feeding days. A novel, multinutrient, human milk-based HMF is well tolerated and meets the nutrition needs of preterm infants.
Sections du résumé
BACKGROUND
The objective of this study was to determine whether human milk supplemented with a novel human milk-based human milk fortifier (Novel HMF), compared with a bovine milk-based HMF (Bovine HMF), supports preterm infant growth through 36 weeks' postmenstrual age (PMA).
METHODS
This single-center, prospective trial compared growth and nutrition outcomes of preterm infants provided a human milk-based diet (mother's own milk or donor milk) supplemented with a Novel HMF with historic controls provided Bovine HMF. Preterm infants with an estimated gestational age (EGA) between 23 and 33 weeks' PMA and birth weight between 750 and 1800 g were eligible for study inclusion. Weight, length, and head circumference (HC) were monitored weekly. The occurrence of late-onset sepsis, nil per os (NPO) days, necrotizing enterocolitis, metabolic acidosis, and serious adverse events were monitored.
RESULTS
Birth weight, length, HC, and EGA were similar between the Novel HMF (n = 37) and Bovine HMF (n = 49) groups. The days to regain birth weight was shorter in the Novel HMF group (9.4 ± 4.0 vs 11.4 ± 4.8, P = .0343), with similar weight gain (g/day) from birth to 36 weeks' PMA. Adjusted weight growth velocity (g/kg/day) was significantly higher in the Novel HMF group at 14 and 21 days but similar at 36 weeks' PMA. The Novel HMF group experienced fewer NPO days with a similar total number of feeding days.
CONCLUSIONS
A novel, multinutrient, human milk-based HMF is well tolerated and meets the nutrition needs of preterm infants.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
817-827Informations de copyright
© 2021 American Society for Parenteral and Enteral Nutrition.
Références
Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010:156(4):562-567.
Cristofalo EA, Schanler RJ, Blanco CL, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. 2013;163(6):1592-1595.
Ghandehari H, Lee ML, Rechtman DJ; H2MF Study Group. An exclusive human milk-based diet in extremely premature infants reduces the probability of remaining on total parenteral nutrition: a reanalysis of the data. BMC Res Notes. 2012:5(1):188.
Stoll BJ, Hansen NI, Bell EJ, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal Outcomes of Extremely Preterm Infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443-456.
Madore LS, Bora S, Erdei C, Jumani T, Dengos AR, Sen S. Effects of donor breastmilk feeding on growth and early neurodevelopmental outcomes in preterm infants: an observational study. Clinical Therapies. 2017;39(6):1210-1120.
Feldman R, Eidelman AI. Direct and indirect effects of breast milk on the neurobehavioral and cognitive development of premature infants. Dev Psychobiol. 2003;43(2):109-119.
Quigley M, Embleton ND, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev. 2019;7(7):CD002971.
Meinzen-Derr J, Poindexter B, Wrage L, Morrow AL, Stoll B, Donovan EF. Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J Perinatol. 2009;29(1):57-62.
Victoria CG BR, Barros AJD, Franca GVA, Horton S, Krasevec J. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475-490.
Breastfeeding and the use of human milk. Pediatrics. 2012;123(3):e827-e841.
Gates A, Marin T, Leo G, Stansfield BK. Review of preterm human-milk nutrient composition. Nutr Clin Pract. Accepted manuscript. Published online August 30, 2020. https://doi.org/10.1002/ncp.10570
Bhatia J. Human milk and the premature infant. Ann Nutr Metab. 2013;62(suppl 3):8-14.
Underwood MA. Human milk for the premature infant. Pediatr Clin North Am. 2013;60(1):189-207.
Koletzko B, Poindexter B, Uauy R. Recommended nutrient intake levels for stable, fully enterally fed very low birth weight infants. In: Koletzko B, Poindexter B, Uauy R, eds. Nutritional Care of Preterm Infants. Scientific Basis and Practical Guidelines. Karger; 2010:297-299.
Casavale KO, Ahuja JKC, Wu X, et al. NIH workshop on human milk composition: summary and visions. Am J Clin Nutr. 2019;110(3):769-779.
Arslanoglu S, Boquien CY, King C, et al. Fortification of human milk for preterm infants: update and recommendations of the European Milk Bank Association (EMBA) working group on human milk fortification. Front Pediatr. 2019;7:76.
Thoene M, Hanson C, Lyden E, Dugick L, Ruybal L, Anderson-Berry A. Comparison of the effect of two human milk fortifiers on clinical outcomes in premature infants. Nutrients. 2014;6(1):261-275.
Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156(4):562-567.
O'Connor DL, Kiss A, Tomlinson C, et al. Nutrient enrichment of human milk with human and bovine milk-based fortifiers for infants born weighing <1250 g: a randomized clinical trial. Am J Clin Nutr. 2018;108(1):108-116.
Eibensteiner F, Auer-Hackenberg L, Jilma B, Thanhaeuser M, Wald M, Haiden N. Growth, feeding tolerance and metabolism in extreme preterm infants under an exclusive human milk diet. Nutrients. 2019;11(7):1443.
Perrin MT. Donor human milk and fortifier use in United States level 2, 3, and 4 neonatal care hospitals. J Pediatr Gastroenterol Nutr. 2018;66(4):664-669.
Fenton TR, Nasser R, Eliasziw M, Kim JH, Bilan D, Sauve R. Validating the weight gain of preterm infants between the reference growth curve of the fetus and the term infant. BMC Pediatr. 2013;13(1):92.
Juhl SM, Hansen ML, Gormsen M, Skov T, Greisen G. Staging of necrotising enterocolitis by Bell's criteria is supported by a statistical pattern analysis of clinical and radiological variables. Acta Paediatr. 2019;108(5):842-848.
Fenton TR, Chan HT, Madhu A, et al. Preterm infant growth velocity calculations: a systematic review. Pediatrics. 2017;139(3):e20162045.
Committee on Nutrition; Section on Breastfeeding; Committee on Fetus and Newborn. Donor human milk for the high-risk infant: preparation, safety, and usage options in the United States. Pediatrics. 2017;139(1):e20163440.
Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2012;129(3):e827-e841.
Cole TJ, Statnikov Y, Santhakumaran S, et al. Birth weight and longitudinal growth in infants born below 32 weeks' gestation: a UK population study. Arch Dis Child Fetal Neonatal Ed. 2014;99(1):F34-F40.
Brownell EA, Matson AP, Smith KC, et al. Dose-response relationship between donor human milk, mother's own milk, preterm formula, and neonatal growth outcomes. J Pediatr Gastroenterol Nutr. 2018;67(1):90-96.
Soldateli B, Parker M, Melvin P, Gupta M, Belfort M. Human milk feeding and physical growth in very low-birth-weight infants: a multicenter study. J Perinatol. 2020;40(8):1246-1252.
Castellano Yanez C, Castillo Barrio B, Munoz Labian MDC, et al. Providing very preterm infants with donor human milk led to faster breastfeeding rates but worse biometric gains. Acta Paediatr. 2019;108(4):766-767.
Perrin MT, Belfort MB, Hagadorn JI, et al. The nutritional composition and energy content of donor human milk: a systematic review. Adv Nutr. 2020;11(4):960-970.
Sisk PM, Lambeth TM, Rojas MA, et al. Necrotizing enterocolitis and growth in preterm infants fed predominantly maternal milk, pasteurized donor milk, or preterm formula: a retrospective study. Am J Perinatol. 2017;34(7):676-683.
Kuschel CA, Harding JE. Multicomponent fortified human milk for promoting growth in preterm infants. Cochrane Database Syst Rev. 2004;(1):CD000343.
Ananthan A, Balasubramanian H, Rao S, Patole S. Human milk-derived fortifiers compared with bovine milk-derived fortifiers in preterm infants: a systematic review and meta-analysis. Adv Nutr. 2020;11(5):1325-1333.
Ananthan A, Balasubramanian H, Rao S, Patole S. Response to comments by Prof Abrams and Prof Lucas on ‘Human milk-derived fortifiers compared with bovine milk-derived fortifiers in preterm infants: a systematic review and meta-analysis’. Adv Nutr. 2020;11(6):1713-1715.
Lucas A, Abrams SA. Comment on human milk-derived fortifiers compared with bovine milk-derived fortifiers in preterm infants: a systematic review and meta-analysis. Adv Nutr. 2020;11(6):1712-1713.
Aydemir O, Sarikabadayi YU, Aydemir C, et al. Adjusted poor weight gain for birth weight and gestational age as a predictor of severe ROP in VLBW infants. Eye (Lond). 2011;25(6):725-729.
Binenbaum G, Ying GS, Quinn GE, et al. The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model. Arch Ophthalmol. 2012;130(12):1560-1565.
Porcelli PJ. The influence of early postnatal nutrition on retinopathy of prematurity in extremely low birth weight infants. Early Hum Dev. 2010;86(6):391-396.
VanderVeen DK, Martin CR, Mehendale R, et al. Early nutrition and weight gain in preterm newborns and the risk of retinopathy of prematurity. PLoS One. 2013;8(5):e64325.
Wallace DK, Kylstra JA, Phillips SJ, Hall JG. Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. J AAPOS. 2000;4(6):343-347.
Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006;30(4):200-208.
Wemhoner A, Ortner D, Tschirch E, Strasak A, Rudiger M. Nutrition of preterm infants in relation to bronchopulmonary dysplasia. BMC Pulm Med. 2011;11(1):7.
Rocha G, de Lima FF, Machado AP, et al. Small for gestational age very preterm infants present a higher risk of developing bronchopulmonary dysplasia. J Neonatal Perinatal Med. 2019;12(4):419-427.
Reiss I, Landmann E, Heckmann M, Misselwitz B, Gortner L. Increased risk of bronchopulmonary dysplasia and increased mortality in very preterm infants being small for gestational age. Arch Gynecol Obstet. 2003;269(1):40-44.
Kewitz G, Wudel S, Hopp H, Hopfenmuller W, Vogel M, Roots I. Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia. J Perinat Med. 2008;36(4):359-364.
Havinga J, Williams A, Hassan N, et al. Individualized fluid management in extremely preterm neonates to ensure adequate diuresis without increasing complications. J Perinatol. 2021;41(2):240-246.
Oh W, Poindexter BB, Perritt R, et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr. 2005;147(6):786-790.